Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Surgery in Cervical Cancer.

Fader AN.

N Engl J Med. 2018 Nov 15;379(20):1955-1957. doi: 10.1056/NEJMe1814034. Epub 2018 Oct 31. No abstract available.

PMID:
30379600
2.

Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.

Yen TT, Miyamoto T, Asaka S, Chui MH, Wang Y, Lin SF, Stone RL, Fader AN, Asaka R, Kashima H, Shiozawa T, Wang TL, Shih IM, Tanner EJ 3rd.

Gynecol Oncol. 2018 Sep;150(3):426-431. doi: 10.1016/j.ygyno.2018.06.025. Epub 2018 Jul 4.

PMID:
30126589
3.

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.

Pisanic TR 2nd, Cope LM, Lin SF, Yen TT, Athamanolap P, Asaka R, Nakayama K, Fader AN, Wang TH, Shih IM, Wang TL.

Clin Cancer Res. 2018 Aug 14. doi: 10.1158/1078-0432.CCR-18-1199. [Epub ahead of print]

PMID:
30108103
4.

Advanced ovarian cancer treated in pregnancy and detected by cell-free DNA aneuploidy screening.

Cordeiro Mitchell CN, Murdock T, Fader AN, Stone RL.

Gynecol Oncol Rep. 2018 Mar 23;24:48-50. doi: 10.1016/j.gore.2018.03.006. eCollection 2018 May.

5.

Is there evidence of a July effect among patients undergoing hysterectomy surgery?

Varma S, Mehta A, Hutfless S, Stone RL, Wethington SL, Fader AN.

Am J Obstet Gynecol. 2018 Aug;219(2):176.e1-176.e9. doi: 10.1016/j.ajog.2018.05.033. Epub 2018 Jun 2.

PMID:
29870735
6.

Effects of the Affordable Care Act on Young Women With Gynecologic Cancers.

Smith AJB, Fader AN.

Obstet Gynecol. 2018 Jun;131(6):966-976. doi: 10.1097/AOG.0000000000002592. Erratum in: Obstet Gynecol. 2018 Sep;132(3):786-787.

PMID:
29742668
7.

Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementation.

Bergstrom JE, Scott ME, Alimi Y, Yen TT, Hobson D, Machado KK, Tanner EJ 3rd, Fader AN, Temkin SM, Wethington S, Levinson K, Sokolinsky S, Lau B, Stone RL.

Gynecol Oncol. 2018 Jun;149(3):554-559. doi: 10.1016/j.ygyno.2018.04.003. Epub 2018 Apr 13.

PMID:
29661495
8.

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.

Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD.

J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27.

PMID:
29584549
9.

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I, Sundfelt K, Kjær SK, Hruban RH, Shih IM, Wang TL, Kurman RJ, Springer S, Ptak J, Popoli M, Schaefer J, Silliman N, Dobbyn L, Tanner EJ, Angarita A, Lycke M, Jochumsen K, Afsari B, Danilova L, Levine DA, Jardon K, Zeng X, Arseneau J, Fu L, Diaz LA Jr, Karchin R, Tomasetti C, Kinzler KW, Vogelstein B, Fader AN, Gilbert L, Papadopoulos N.

Sci Transl Med. 2018 Mar 21;10(433). pii: eaap8793. doi: 10.1126/scitranslmed.aap8793.

PMID:
29563323
10.

Interventional Radiation Oncology (IRO): Transition of a magnetic resonance simulator to a brachytherapy suite.

Anderson R, Armour E, Beeckler C, Briner V, Choflet A, Cox A, Fader AN, Hannah MN, Hobbs R, Huang E, Kiely M, Lee J, Morcos M, McMillan PE, Miller D, Ng SK, Prasad R, Souranis A, Thomsen R, DeWeese TL, Viswanathan AN.

Brachytherapy. 2018 May - Jun;17(3):587-596. doi: 10.1016/j.brachy.2018.01.007. Epub 2018 Mar 13.

PMID:
29548553
11.

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL.

J Natl Compr Canc Netw. 2018 Feb;16(2):170-199. doi: 10.6004/jnccn.2018.0006.

PMID:
29439178
12.

Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.

Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM Jr, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN.

Gynecol Oncol. 2018 Mar;148(3):480-484. doi: 10.1016/j.ygyno.2018.01.002. Epub 2018 Jan 12.

PMID:
29338923
13.

Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.

Ojalvo LS, Thompson ED, Wang TL, Meeker AK, Shih IM, Fader AN, Cimino-Mathews A, Emens LA.

Hum Pathol. 2018 Apr;74:135-147. doi: 10.1016/j.humpath.2017.12.010. Epub 2017 Dec 27.

PMID:
29288043
14.

Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.

Ricci S, Tergas AI, Long Roche K, Fairbairn MG, Levinson KL, Dowdy SC, Bristow RE, Lopez M, Slaughter K, Moore K, Fader AN.

Gynecol Oncol Rep. 2017 Nov 15;22:100-104. doi: 10.1016/j.gore.2017.11.006. eCollection 2017 Nov.

15.

Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.

Tanner E, Puechl A, Levinson K, Havrilesky LJ, Sinno A, Secord AA, Fader AN, Lee PS.

Gynecol Oncol. 2017 Dec;147(3):535-540. doi: 10.1016/j.ygyno.2017.10.020. Epub 2017 Oct 19.

PMID:
29056441
16.

Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.

Levinson KL, Riedel DJ, Ojalvo LS, Chan W, Angarita AM, Fader AN, Rositch AF.

AIDS. 2018 Jan 14;32(2):171-177. doi: 10.1097/QAD.0000000000001664.

PMID:
29028665
17.

Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.

Lippitt MH, Fairbairn MG, Matsuno R, Stone RL, Tanner EJ 3rd, Wick EC, Angarita AC, Roche KL, Levinson KL, Bergstrom JE, Sinno AK, Curless MS, Wethington S, Temkin SM, Efron J, Hobson D, Fader AN.

Obstet Gynecol. 2017 Oct;130(4):756-764. doi: 10.1097/AOG.0000000000002213.

PMID:
28885412
18.

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

Fader AN, Bergstrom J, Jernigan A, Tanner EJ 3rd, Roche KL, Stone RL, Levinson KL, Ricci S, Wethingon S, Wang TL, Shih IM, Yang B, Zhang G, Armstrong DK, Gaillard S, Michener C, DeBernardo R, Rose PG.

Gynecol Oncol. 2017 Oct;147(1):85-91. doi: 10.1016/j.ygyno.2017.07.127. Epub 2017 Jul 30.

PMID:
28768570
19.

Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis.

Moukarzel LA, Sinno AK, Fader AN, Tanner EJ.

J Minim Invasive Gynecol. 2017 Sep - Oct;24(6):977-983. doi: 10.1016/j.jmig.2017.05.016. Epub 2017 Jun 7.

PMID:
28599884
20.

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr.

Science. 2017 Jul 28;357(6349):409-413. doi: 10.1126/science.aan6733. Epub 2017 Jun 8.

21.

Distress Screening: Evaluating a Protocol for Gynecologic Cancer Survivors
.

Johnson C, George M, Fader AN.

Clin J Oncol Nurs. 2017 Jun 1;21(3):353-361. doi: 10.1188/17.CJON.353-361.

22.

Minimally Invasive Techniques for Treating Gynecologic Malignancies.

Fader AN.

J Natl Compr Canc Netw. 2017 May;15(5S):730-732.

23.

New Developments in Minimally Invasive Gynecologic Oncology Surgery.

Stewart KI, Fader AN.

Clin Obstet Gynecol. 2017 Jun;60(2):330-348. doi: 10.1097/GRF.0000000000000286. Review.

24.

Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.

Sinno AK, Li X, Thompson RE, Tanner EJ 3rd, Levinson KL, Stone RL, Temkin SM, Fader AN, Chi DS, Long Roche K.

Gynecol Oncol. 2017 Jun;145(3):493-499. doi: 10.1016/j.ygyno.2017.03.020. Epub 2017 Mar 30.

25.

Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.

Ricci S, Stone RL, Fader AN.

Gynecol Oncol. 2017 Apr;145(1):208-216. doi: 10.1016/j.ygyno.2017.02.019. Epub 2017 Feb 13. Review.

PMID:
28209496
26.

Cancer Implications for Patients with Endometriosis.

Wilbur MA, Shih IM, Segars JH, Fader AN.

Semin Reprod Med. 2017 Jan;35(1):110-116. doi: 10.1055/s-0036-1597120. Epub 2017 Jan 3. Review.

PMID:
28049216
27.

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J.

J Natl Compr Canc Netw. 2017 Jan;15(1):92-120.

PMID:
28040721
28.

Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications.

Mehta A, Xu T, Hutfless S, Makary MA, Sinno AK, Tanner EJ 3rd, Stone RL, Wang K, Fader AN.

Am J Obstet Gynecol. 2017 May;216(5):497.e1-497.e10. doi: 10.1016/j.ajog.2016.12.020. Epub 2016 Dec 26.

29.

Perioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer.

Desale MG, Tanner EJ 3rd, Sinno AK, Angarita AA, Fader AN, Stone RL, Levinson KL, Bristow RE, Roche KL.

Gynecol Oncol. 2016 Oct 28. pii: S0090-8258(16)31501-3. doi: 10.1016/j.ygyno.2016.10.027. [Epub ahead of print]

PMID:
28029449
30.

Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis.

Moukarzel LA, Angarita AM, VandenBussche C, Rositch A, Thompson CB, Fader AN, Levinson K.

J Low Genit Tract Dis. 2017 Apr;21(2):91-96. doi: 10.1097/LGT.0000000000000286.

31.

Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.

Bodurtha Smith AJ, Fader AN, Tanner EJ.

Am J Obstet Gynecol. 2017 May;216(5):459-476.e10. doi: 10.1016/j.ajog.2016.11.1033. Epub 2016 Nov 18. Review.

PMID:
27871836
32.

Feasibility of Robotic-Assisted Laparoendoscopic Single-Site Surgery in the Gynecologic Oncology Setting.

Moukarzel LA, Fader AN, Tanner EJ.

J Minim Invasive Gynecol. 2017 Feb;24(2):258-263. doi: 10.1016/j.jmig.2016.10.013. Epub 2016 Nov 1.

PMID:
27815041
33.

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.

Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL.

Cancer Res. 2016 Nov 1;76(21):6351-6361. Epub 2016 Sep 2.

34.

A perverse quality incentive in surgery: implications of reimbursing surgeons less for doing laparoscopic surgery.

Fader AN, Xu T, Dunkin BJ, Makary MA.

Surg Endosc. 2016 Nov;30(11):4665-4667. Epub 2016 Oct 17. Review.

35.

Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer.

Sinno AK, Peijnenburg E, Fader AN, Temkin SM, Stone R, Levinson K, Murdock T, Tanner EJ.

Gynecol Oncol. 2016 Nov;143(2):281-286. doi: 10.1016/j.ygyno.2016.08.323. Epub 2016 Aug 24.

PMID:
27568279
36.

Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer.

Beavis AL, Salazar-Marioni S, Sinno AK, Stone RL, Fader AN, Santillan-Gomez A, Tanner EJ 3rd.

Gynecol Oncol. 2016 Nov;143(2):302-306. doi: 10.1016/j.ygyno.2016.08.236. Epub 2016 Aug 12.

37.

Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.

Fader AN, Java J, Tenney M, Ricci S, Gunderson CC, Temkin SM, Spirtos N, Kushnir CL, Pearl ML, Zivanovic O, Tewari KS, O'Malley D, Hartenbach EM, Hamilton CA, Gould NS, Mannel RS, Rodgers W, Walker JL.

Gynecol Oncol. 2016 Dec;143(3):460-465. doi: 10.1016/j.ygyno.2016.10.016. Epub 2016 Oct 12.

38.

Feasibility of Robotic Laparoendoscopic Single Site Surgery in the Gynecologic Oncology Setting.

Moukarzel L, Fader AN, Tanner EJ.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S49. doi: 10.1016/j.jmig.2015.08.135. Epub 2015 Oct 15. No abstract available.

PMID:
27679258
39.

Warm-Up Before Robotic Hysterectomy Does Not Improve Trainee Operative Performance: A Randomized Trial.

Chen C, Tanner E, Malpani A, Vedula SS, Fader AN, Scheib SA, Green IC, Hager GD.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S34. doi: 10.1016/j.jmig.2015.08.093. Epub 2015 Oct 15. No abstract available.

PMID:
27679212
40.

Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.

Wilbur MB, Mannschreck DB, Angarita AM, Matsuno RK, Tanner EJ, Stone RL, Levinson KL, Temkin SM, Makary MA, Leung CA, Deutschendorf A, Pronovost PJ, Brown A, Fader AN.

Gynecol Oncol. 2016 Dec;143(3):604-610. doi: 10.1016/j.ygyno.2016.09.020. Epub 2016 Sep 21.

PMID:
27665313
41.

"Little Big Things": A Qualitative Study of Ovarian Cancer Survivors and Their Experiences With the Health Care System.

Long Roche K, Angarita AM, Cristello A, Lippitt M, Haider AH, Bowie JV, Fader AN, Tergas AI.

J Oncol Pract. 2016 Dec;12(12):e974-e980. Epub 2016 Oct 31.

PMID:
27601509
42.

The Use of "Optimal Cytoreduction" Nomenclature in Ovarian Cancer Literature: Can We Move Toward a More Optimal Classification System?

Angarita AM, Stone R, Temkin SM, Levinson K, Fader AN, Tanner EJ.

Int J Gynecol Cancer. 2016 Oct;26(8):1421-7. doi: 10.1097/IGC.0000000000000796.

PMID:
27575626
43.

Disparities in Surgical Care Among Women With Endometrial Cancer.

Mannschreck D, Matsuno RK, Moriarty JP, Borah BJ, Dowdy SC, Tanner EJ 3rd, Makary MA, Stone RL, Levinson KL, Temkin SM, Fader AN.

Obstet Gynecol. 2016 Sep;128(3):526-34. doi: 10.1097/AOG.0000000000001567.

PMID:
27500330
44.

Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis.

Fader AN, Habermann EB, Hanson KT, Lin JF, Grendys EC, Dowdy SC.

Gynecol Oncol. 2016 Oct;143(1):98-104. doi: 10.1016/j.ygyno.2016.07.107. Epub 2016 Jul 26.

PMID:
27470998
45.

Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management.

Beavis AL, Smith AJ, Fader AN.

Int J Womens Health. 2016 May 23;8:151-67. doi: 10.2147/IJWH.S88367. eCollection 2016. Review.

46.

Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer.

Angarita AM, Johnson CA, Fader AN, Christianson MS.

Front Oncol. 2016 Apr 25;6:102. doi: 10.3389/fonc.2016.00102. eCollection 2016. Review.

47.

Trans-surgical Disciplines Collaboration Is an Effective Strategy for Expediting Quality Improvement.

Wick EC, Pronovost PJ, Fader AN.

Ann Surg. 2016 Dec;264(6):915-916. No abstract available.

PMID:
27140511
48.

An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.

Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J.

J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):303-8. doi: 10.1016/j.jmig.2015.12.012. Epub 2016 Jan 8. No abstract available.

PMID:
26773577
49.

Transfusion medicine illustrated. Massive transfusion in an obstetric emergency.

Hulse M, Fader AN, Shan H, Benneh N, Tobian AA.

Transfusion. 2016 Jan;56(1):23. doi: 10.1111/trf.13391. No abstract available.

PMID:
26756709
50.

Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.

Cholakian D, Hacker K, Fader AN, Gehrig PA, Tanner EJ 3rd.

Gynecol Oncol. 2016 Feb;140(2):234-8. doi: 10.1016/j.ygyno.2015.12.010. Epub 2015 Dec 17.

PMID:
26706662

Supplemental Content

Loading ...
Support Center